CSPG4 and melanoma: Therefore, across disparate in vivo models of melanoma in immunodeficient mice engrafted with healthy volunteer or melanoma patient immune cells and in PDX-bearing mice reconstituted with autologous patient immune cells, CSPG4 IgE was associated with significant tumor growth restriction or improved survival, compared to controls.